table of contents table of contents

In this report, by inclusion of multiple components of the HIV genome, …

Home » Biology Articles » Virology » Rev-dependent lentiviral expression vector » References

- Rev-dependent lentiviral expression vector

  1. Felber BK, Pavlakis GN: A Quantitative Bioassay for Hiv-1 Based on Trans-Activation.

    Science 1988, 239(4836):184-187.

  2. Schwartz S, Felber BK, Fenyo EM, Pavlakis GN: Rapidly and Slowly Replicating Human Immunodeficiency Virus Type-1 Isolates Can Be Distinguished According to Target-Cell Tropism in T-Cell and Monocyte Cell-Lines.

    Proc Natl Acad Sci U S A 1989, 86(18):7200-7203.

  3. Rocancourt D, Bonnerot C, Jouin H, Emerman M, Nicolas JF: Activation of a Beta-Galactosidase Recombinant Provirus - Application to Titration of Human-Immunodeficiency-Virus (Hiv) and Hiv-Infected Cells.

    J Virol 1990, 64(6):2660-2668.

  4. Kimpton J, Emerman M: Detection of Replication-Competent and Pseudotyped Human-Immunodeficiency-Virus with a Sensitive Cell-Line on the Basis of Activation of an Integrated Beta-Galactosidase Gene.

    Journal of Virology 1992, 66(4):2232-2239.

  5. Muesing MA, Smith DH, Capon DJ: Regulation of Messenger-Rna Accumulation by a Human-Immunodeficiency-Virus Transactivator Protein.

    Cell 1987, 48(4):691-701.

  6. Dingwall C, Ernberg I, Gait MJ, Green SM, Heaphy S, Karn J, Lowe AD, Singh M, Skinner MA, Valerio R: Human Immunodeficiency Virus-1 Tat Protein Binds Trans-Activation-Responsive Region (Tar) Rna Invitro.

    Proceedings of the National Academy of Sciences of the United States of America 1989, 86(18):6925-6929.

  7. Berkhout B, Silverman RH, Jeang KT: Tat Trans-Activates the Human Immunodeficiency Virus through a Nascent Rna Target.

    Cell 1989, 59(2):273-282.

  8. Kao SY, Calman AF, Luciw PA, Peterlin BM: Anti-Termination of Transcription within the Long Terminal Repeat of Hiv-1 by Tat Gene-Product.

    Nature 1987, 330(6147):489-493.

  9. Laspia MF, Rice AP, Mathews MB: Hiv-1 Tat Protein Increases Transcriptional Initiation and Stabilizes Elongation.

    Cell 1989, 59(2):283-292.

  10. Kato H, Sumimoto H, Pognonec P, Chen CH, Rosen CA, Roeder RG: Hiv-1 Tat Acts as a Processivity Factor Invitro in Conjunction with Cellular Elongation-Factors.

    Genes & Development 1992, 6(4):655-666.

  11. Raha T, Cheng SWG, Green MR: HIV-1 Tat stimulates transcription complex assembly through recruitment of TBP in the absence of TAFs.

    Plos Biology 2005, 3(2):221-230.

  12. Brady J, Kashanchi F: Tat gets the "green" light on transcription initiation.

    Retrovirology 2005., 2:

  13. Jordan A, Defechereux P, Verdin E: The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation.

    Embo Journal 2001, 20(7):1726-1738.

  14. Gervaix A, West D, Leoni LM, Richman DD, WongStaal F, Corbeil J: A new reporter cell line to monitor HIV infection and drug susceptibility in vitro.

    Proceedings of the National Academy of Sciences of the United States of America 1997, 94(9):4653-4658.

  15. Feinberg MB, Jarrett RF, Aldovini A, Gallo RC, Wongstaal F: Htlv-Iii Expression and Production Involve Complex Regulation at the Levels of Splicing and Translation of Viral-Rna.

    Cell 1986, 46(6):807-817.

  16. Malim MH, Hauber J, Fenrick R, Cullen BR: Immunodeficiency Virus Rev Trans-Activator Modulates the Expression of the Viral Regulatory Genes.

    Nature 1988, 335(6186):181-183.

  17. Emerman M, Vazeux R, Peden K: The Rev Gene-Product of the Human Immunodeficiency Virus Affects Envelope-Specific Rna Localization.

    Cell 1989, 57(7):1155-1165.

  18. Robertguroff M, Popovic M, Gartner S, Markham P, Gallo RC, Reitz MS: Structure and Expression of Tat-Specific, Rev-Specific, and Nef-Specific Transcripts of Human-Immunodeficiency-Virus Type-1 in Infected Lymphocytes and Macrophages.

    Journal of Virology 1990, 64(7):3391-3398.

  19. Purcell DFJ, Martin MA: Alternative Splicing of Human-Immunodeficiency-Virus Type-1 Messenger-Rna Modulates Viral Protein Expression, Replication, and Infectivity.

    Journal of Virology 1993, 67(11):6365-6378.

  20. Kim SY, Byrn R, Groopman J, Baltimore D: Temporal Aspects of DNA and Rna-Synthesis During Human Immunodeficiency Virus-Infection - Evidence for Differential Gene-Expression.

    Journal of Virology 1989, 63(9):3708-3713.

  21. Klotman ME, Kim S, Buchbinder A, Derossi A, Baltimore D, Wongstaal F: Kinetics of Expression of Multiply Spliced Rna in Early Human-Immunodeficiency-Virus Type-1 Infection of Lymphocytes and Monocytes.

    Proceedings of the National Academy of Sciences of the United States of America 1991, 88(11):5011-5015.

  22. Sodroski J, Goh WC, Rosen C, Dayton A, Terwilliger E, Haseltine W: A 2nd Posttranscriptional Transactivator Gene Required for Htlv-Iii Replication.

    Nature 1986, 321(6068):412-417.

  23. Knight DM, Flomerfelt FA, Ghrayeb J: Expression of the Art Trs Protein of Hiv and Study of Its Role in Viral Envelope Synthesis.

    Science 1987, 236(4803):837-840.

  24. Schwartz S, Campbell M, Nasioulas G, Harrison J, Felber BK, Pavlakis GN: Mutational Inactivation of an Inhibitory Sequence in Human-Immunodeficiency-Virus Type-1 Results in Rev-Independent Gag Expression.

    Journal of Virology 1992, 66(12):7176-7182.

  25. Kotsopoulou E, Kim VN, Kingsman AJ, Kingsman SM, Mitrophanous KA: A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene.

    Journal of Virology 2000, 74(10):4839-4852.

  26. Hope TJ, Huang XJ, McDonald D, Parslow TG: Steroid-Receptor Fusion of the Human-Immunodeficiency-Virus Type-1 Rev Transactivator - Mapping Cryptic Functions of the Arginine-Rich Motif.

    Proceedings of the National Academy of Sciences of the United States of America 1990, 87(19):7787-7791.

  27. Ragheb JA, Bressler P, Daucher M, Chiang L, Chuah MKL, Vandendriessche T, Morgan RA: Analysis of Transdominant Mutants of the Hiv Type-1 Rev Protein for Their Ability to Inhibit Rev Function, Hiv Type-1 Replication, and Their Use as Anti-Hiv Gene Therapeutics.

    Aids Research and Human Retroviruses 1995, 11(11):1343-1353.

  28. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D: In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.

    Science 1996, 272(5259):263-267.

  29. He JL, Choe S, Walker R, Dimarzio P, Morgan DO, Landau NR: Human-Immunodeficiency-Virus Type-1 Viral-Protein-R (Vpr) Arrests Cells in the G(2) Phase of the Cell-Cycle by Inhibiting P34(Cdc2) Activity.

    Journal of Virology 1995, 69(11):6705-6711.

  30. Henderson AJ, Calame KL: CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4(+) T cells.

    Proceedings of the National Academy of Sciences of the United States of America 1997, 94(16):8714-8719.

  31. Lee ES, Sarma D, Zhou HY, Henderson AJ: CCAAT/enhancer binding proteins are not required for HIV-1 entry but regulate proviral transcription by recruiting coactivators to the long-terminal repeat in monocytic cells.

    Virology 2002, 299(1):20-31.

  32. Orenstein JM, Meltzer MS, Phipps T, Gendelman HE: Cytoplasmic Assembly and Accumulation of Human Immunodeficiency Virus Type-1 and Type-2 in Recombinant Human Colony-Stimulating Factor-1-Treated Human-Monocytes - an Ultrastructural-Study.

    Journal of Virology 1988, 62(8):2578-2586.

  33. Pelchen-Matthews A, Kramer B, Marsh M: Infectious HIV-1 assembles in late endosomes in primary macrophages.

    Journal of Cell Biology 2003, 162(3):443-455.

  34. Bagasra O, Hauptman SP, Lischner HW, Sachs M, Pomerantz RJ: Detection of Human-Immunodeficiency-Virus Type-1 Provirus in Mononuclear-Cells by Insitu Polymerase Chain-Reaction.

    New England Journal of Medicine 1992, 326(21):1385-1391.

  35. Patterson BK, Till M, Otto P, Goolsby C, Furtado MR, McBride LJ, Wolinsky SM: Detection of Hiv-1 DNA and Messenger-Rna in Individual Cells by Pcr-Driven Insitu Hybridization and Flow-Cytometry.

    Science 1993, 260(5110):976-979.

  36. Embretson J, Zupancic M, Beneke J, Till M, Wolinsky S, Ribas JL, Burke A, Haase AT: Analysis of Human Immunodeficiency Virus-Infected Tissues by Amplification and Insitu Hybridization Reveals Latent and Permissive Infections at Single-Cell Resolution.

    Proceedings of the National Academy of Sciences of the United States of America 1993, 90(1):357-361.

  37. Nara PL, Hatch WC, Dunlop NM, Robey WG, Arthur LO, Gonda MA, Fischinger PJ: Simple, Rapid, Quantitative, Syncytium-Forming Microassay for the Detection of Human Immunodeficiency Virus Neutralizing Antibody.

    Aids Research and Human Retroviruses 1987, 3(3):283-302.

  38. Perez VL, Rowe T, Justement JS, Butera ST, June CH, Folks TM: An Hiv-1-Infected T-Cell Clone Defective in Il-2 Production and Ca2+ Mobilization after Cd3 Stimulation.

    Journal of Immunology 1991, 147(9):3145-3148.

  39. Theodore TS, Englund G, BucklerWhite A, Buckler CE, Martin MA, Peden KWC: Construction and characterization of a stable full-length macrophage-tropic HIV type 1 molecular clone that directs the production of high titers of progeny virions.

    Aids Research and Human Retroviruses 1996, 12(3):191-194.

  40. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, Martin MA: Production of Acquired Immunodeficiency Syndrome-Associated Retrovirus in Human and Nonhuman Cells Transfected with an Infectious Molecular Clone.

    Journal of Virology 1986, 59(2):284-291.

  41. Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK: Vesicular Stomatitis-Virus G Glycoprotein Pseudotyped Retroviral Vectors - Concentration to Very High-Titer and Efficient Gene-Transfer into Mammalian and Nonmammalian Cells.

    Proceedings of the National Academy of Sciences of the United States of America 1993, 90(17):8033-8037.

  42. Reed LJ, Muench H: A simple method of estimating fifty percent endpoints.

    American Journal of Hygiene 1938, 27(3):493-497.

  43. Chesebro B, Wehrly K, Nishio J, Perryman S: Macrophage-Tropic Human-Immunodeficiency-Virus Isolates from Different Patients Exhibit Unusual V3 Envelope Sequence Homogeneity in Comparison with T-Cell-Tropic Isolates - Definition of Critical Amino-Acids Involved in Cell Tropism.

    Journal of Virology 1992, 66(11):6547-6554.

  44. Wehrly K, Chesebro B: p24 antigen capture assay for quantification of human immunodeficiency virus using readily available inexpensive reagents.

    Methods-a Companion to Methods in Enzymology 1997, 12(4):288-293.

  45. Toohey K, Wehrly K, Nishio J, Perryman S, Chesebro B: Human-Immunodeficiency-Virus Envelope V1 and V2 Regions Influence Replication Efficiency in Macrophages by Affecting Virus Spread.

    Virology 1995, 213(1):70-79.

rating: 1.00 from 1 votes | updated on: 8 May 2008 | views: 12383 |

Rate article: